James P. Bennett

James P. Bennett publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where James P. Bennett sits on this spectrum.

James P. Bennett D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where James P. Bennett sits on this spectrum.

Best Publications

• Parkinson's Disease Brain Mitochondrial Complex I Has Oxidatively Damaged Subunits and Is Functionally Impaired and Misassembled

  Paula M. Keeney;Jing Xie;Roderick A. Capaldi;James P. Bennett

  915
  Citations

• Origin and functional consequences of the complex I defect in Parkinson's disease

  Swerdlow Rh;Parks Jk;Miller Sw;Tuttle Jb

  813
  Citations

• An evaluation of the role of mitochondria in neurodegenerative diseases : mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration

  David S Cassarino;James P Bennett

  583
  Citations

• The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism

  David S. Cassarino;Janice K. Parks;W.Davis Parker;James P. Bennett

  431
  Citations

• Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease

  Shannon Km;Bennett Jp;Friedman Jh

  400
  Citations

• Cybrids in Alzheimer's disease: A cellular model of the disease?

  R. H. Swerdlow;J. K. Parks;D. S. Cassarino;D. J. Maguire

  379
  Citations

• Abnormal Mitochondrial Morphology in Sporadic Parkinson's and Alzheimer's Disease Cybrid Cell Lines

  Patricia A. Trimmer;Russell H. Swerdlow;Janice K. Parks;Paula Keeney

  372
  Citations

• Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

  James P. Bennett;Salvatore J. Enna;David B. Bylund;J. Christian Gillin

  358
  Citations

• Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease.

  David S Cassarino;Christopher P Fall;Russell H Swerdlow;Trisha S Smith

  339
  Citations

• Postmenopausal estrogen use affects risk for Parkinson disease.

  Lillian J. Currie;Madaline B. Harrison;Joel M. Trugman;James P. Bennett

  309
  Citations

• Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion.

  David S. Cassarino;Christopher P. Fall;Trisha S. Smith;James P. Bennett

  295
  Citations

• Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranes

  George R. Uhl;James P. Bennett;Solomon H. Snyder

  291
  Citations

• Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro.

  Janice K. Parks;Trisha S. Smith;Patricia A. Trimmer;James P. Bennett

  288
  Citations

• Neuroinflammation in Alzheimer's Disease.

  Isaac G. Onyango;Gretsen V. Jauregui;Mária Čarná;James P. Bennett

  276
  Citations

• Huntington's chorea. Changes in neurotransmitter receptors in the brain.

  Salvatore J. Enna;Edward D. Bird;James P. Bennett;David B. Bylund

  256
  Citations

• Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors.

  James P. Bennett;Solomon H. Snyder

  240
  Citations

• Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.

  James P Bennett;Montford F Piercey

  221
  Citations

• Mitochondria in Sporadic Amyotrophic Lateral Sclerosis

  Swerdlow Rh;Parks Jk;Cassarino Ds;Trimmer Pa

  219
  Citations

• Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family

  Russell H. Swerdlow;Janice K. Parks;John N. Davis;David S. Cassarino

  204
  Citations

• Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity

  Patricia A. Trimmer;Trisha S. Smith;Anthony B. Jung;James P. Bennett

  193
  Citations

• Mitochondrial toxins in models of neurodegenerative diseases. I: in vivo brain hydroxyl radical production during sytemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions

  Trisha S Smith;James P Bennett

  185
  Citations

• Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment

  Matthew W. Robertson;Catherine A. Leslie;James P. Bennett

  181
  Citations

• Alterations of brain neurotransmitter receptor binding in Huntington's chorea.

  S.J. Enna;James P. Bennett;David B. Bylund;Solomon H. Snyder

  181
  Citations